The clinical problem

Hormonal systems shift with age, and the effects reach into energy, mood, cognition, body composition, sexual health, and long-term disease risk. Too often these changes are dismissed, or treated with a one-size prescription that ignores the individual picture.

The UroLongevity approach

Hormone optimization here begins with measurement and context — not a reflex prescription. The relevant systems include testosterone, the growth-hormone axis, thyroid function, DHEA, and, importantly, female reproductive hormones. Decisions are individualized, monitored, and revisited as your biology changes.

◆ Dr. Shusterman’s take

Women’s hormone health has been underserved for a generation, partly because of a study whose findings were widely misread. Menopausal hormone therapy deserves a careful, individualized, evidence-current conversation — not a dismissal and not a reflex.

What’s involved

At a high level, evaluation and intervention may include:

  • Comprehensive hormone panels interpreted in the context of symptoms and goals
  • Men’s hormone health — testosterone and related axes, evaluated thoroughly
  • Women’s hormone health — including menopausal hormone therapy, given the serious attention it deserves
  • Thyroid and adrenal markers where the picture warrants
  • Ongoing monitoring — because hormone therapy is a relationship, not a single decision
On dosing Specific dosing and protocols are individualized to your clinical picture and decided in consultation. They are not published here, because one-size guidance is not good medicine.

Honest expectations

Well-managed hormone optimization can meaningfully improve quality of life for the right patient. It also carries real considerations that must be weighed individually. The right answer is sometimes treatment, sometimes monitoring, and sometimes that the cause lies elsewhere. Honest evaluation is the point.